Ovid Therapeutics Inc. (OVID)
NASDAQ: OVID · Real-Time Price · USD
2.830
+0.030 (1.07%)
At close: Aug 14, 2026, 4:00 PM EDT
2.780
-0.050 (-1.77%)
After-hours: Aug 14, 2026, 7:34 PM EDT
Ovid Therapeutics Market Cap
Ovid Therapeutics has a market cap or net worth of $552.69 million as of August 14, 2026. Its market cap has increased by 806.05% in one year.
Market Cap
552.69M
Enterprise Value
395.64M
1-Year Change
806.05%
Ranking
Category
Stock Price
$2.83
ChartMarket Cap Chart
Since May 5, 2017, Ovid Therapeutics's market cap has increased from $301.40M to $552.69M, an increase of 83.38%. That is a compound annual growth rate of 6.75%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2026 | 552.70M | 376.06% |
| Dec 31, 2025 | 116.10M | 75.11% |
| Dec 31, 2024 | 66.30M | -70.87% |
| Dec 29, 2023 | 227.60M | 73.61% |
| Dec 30, 2022 | 131.10M | -40.03% |
| Dec 31, 2021 | 218.60M | 49.22% |
| Dec 31, 2020 | 146.50M | -26.16% |
| Dec 31, 2019 | 198.40M | 232.33% |
| Dec 31, 2018 | 59.70M | -75.41% |
| Dec 29, 2017 | 242.80M | -19.44% |
| May 5, 2017 | 301.40M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Evommune | 512.44M |
| Relmada Therapeutics | 503.48M |
| OmniAb | 497.24M |
| Rezolute | 490.99M |
| Kyverna Therapeutics | 489.40M |
| Ginkgo Bioworks Holdings | 485.52M |
| Entera Bio | 484.80M |
| C4 Therapeutics | 479.80M |